Leukemia section

Leukemia News and Features

Researchers develop potential drug for rare leukemia

Researchers have developed a new drug that shows potential as a treatment for a rare type of acute leukemia, according to a recent study.

Study pinpoints genetic cause of increased leukemia risk

A mutation of the gene ETV6 has been pinpointed as the heritable, genetic cause of acute lymphoblastic leukemia (ALL), according to a study.

Promising drug offers new paradigm for treating leukemia

Researchers have developed a compound that delays leukemia in mice and kills leukemia cells in human tissue samples, which gives hope it could be used to improve regular leukemia therapy.

Use of pharmacokinetics to measure response in CML

Use of pharmacokinetics to measure response in CML

What data are available concerning inter- and intrapatient variability in the pharmacokinetics of TKIs in chronic myeloid leukemia?

Measuring treatment response is essential to guiding leukemia treatment

Measuring treatment response is essential to guiding leukemia treatment

A measurement of the concentration of leukemia cells in patient bone marrow during the first 46 days of chemotherapy may allow for better matching of patients to the optimal intensity of chemotherapy.

April Contest

Click here to get started

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs